MRD Monitoring Market Assessment and Strategy

Primary Research

• Conducted 30 interviews with clinicians and biopharma stakeholders to assess the opportunities for MRD in research and clinical diagnostics
• Assessed the pain-points and unmet needs associated with existing offerings, and the desired methods, performance specifications, configurations, and workflows for an ideal offering
• Specified and prioritized the indications and applications where MRD and monitoring is most impactful, and the product requirements needed for each application

Secondary Research

• Assessed the competitive landscape and clinical workflows in specific indications to understand how the company fits in; reviewed clinical trial activity to identify competitive gaps where new players can compete
• Assessed epidemiology and clinical workflows to understand the relatives sizes of the different MRD / monitoring applications by cancer type

‍

DeciBio presented to the client a deliverable discussing discrete use cases of the highest interest to the client team, and deep dives of each. Additional content include:

• U.S. ctDNA MRD and monitoring landscape size
• Top use case prioritized by client differentiation and attractiveness
• Primary feedback highlights regarding potential utility by indication